A new study from the MRC Laboratory of Medical Sciences (LMS) in London, UK reveals how ancient viral DNA once written off as ...

It's a common storytelling trope: the stubborn foe who is eventually revealed to be a much-needed friend. Biology has its own ...

Alcohol consumption leads to the formation of a toxic compound called acetaldehyde, which damages DNA. A research team from ...

In an article published in Nature Microbiology, scientists reveal the existence of numerous new lineages of mirusviruses, ...

In the dim waters off the Japanese coast, scientists have stumbled upon something that shouldn’t exist. Or at least not by ...

A new study reports that the locations where genes begin are particularly prone to mutations, and these genetic changes can be inherited by later generations. Researchers have identified previously ...

This work provides high-precision single-cell data on the relationship between DnaA activity and cell size, offering important insights for the field of cell cycle control. These findings motivate a ...

DNA replication is a semi-conservative process in which half of the newly synthesized strands (daughters) are derived from the original strands (mothers). The confirmation of semi-conservative ...

Fans have speculated for months about Stefon Diggs and his alleged paternity drama. The drama has followed Cardi B, which has caused her to address messy rumors about the New England Patriots’ wide ...

Amanda Kay Montoya is an Associate Professor at the University of California, Los Angeles. She serves on the Board of Directors for the Center for Open Science. She receives funding from the ...

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.

Phase 2 trial of ozuriftamab vedotin (BA3021), a conditionally binding ROR2-ADC, in patients with heavily pretreated squamous cell carcinoma of the head and neck. Mechanisms of resistance to anti-PD1 ...